1% Tirbanibulin Ointment for the Treatment of Actinic Keratoses

Patient‐reported outcomes of topical therapies in actinic keratosis: A systematic review

(2021) Ayman Grada et al.   Dermatologic Therapy

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis

(2021) Andrew Blauvelt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness

(2021) Veronica K. Emmerich et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Actinic keratosis: where do we stand and where is the future going to take us?

(2020) Philipp Cramer et al.   EXPERT OPINION ON EMERGING DRUGS

Current therapies for actinic keratosis

(2020) Caterina Dianzani et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Core Outcome Set for Actinic Keratosis Clinical Trials

(2020) Kelly A. Reynolds et al.   JAMA Dermatology

Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects

(2019) Clarissa Prieto Herman Reinehr et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

Reversible binding of the anticancer drug KXO1 (tirbanibulin) to the colchicine-binding site of β-tubulin explains KXO1's low clinical toxicity

(2019) Lu Niu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review

(2017) Patrick Fleming et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Actinic Keratosis

(2016) Mark Lebwohl   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology

(2016) Thomas Dirschka et al.   JOURNAL OF DERMATOLOGICAL TREATMENT